Apyx Medical (APYX) Corporation announces it has received 510(k) clearance from the U.S. Food and Drug Administration for the AYON Body Contouring System. The Company is actively preparing for a commercial launch of AYON with key surgeons in critical geographies starting in the second half of 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APYX: